LINC01111 and pancreatic neoplasm: LINC01111, identified as an oncosuppressor in pancreatic cancer [32], and the annotated LHX1-DT and AC006387.1 transcripts were also significantly enriched in the DA population (Figure 6F and Supplementary Table S3).